1. Get the Diabetes Forum App for your phone - available on iOS and Android.
    Dismiss Notice
  2. Guest, we'd love to know what you think about the forum! Take the Diabetes Forum Survey 2021 »
    Dismiss Notice
  3. Diabetes Forum should not be used in an emergency and does not replace your healthcare professional relationship. Posts can be seen by the public.
    Dismiss Notice
  4. Guest, stay home, stay safe, save the NHS. Stay up to date with information about keeping yourself and people around you safe here and GOV.UK: Coronavirus (COVID-19). Think you have symptoms? NHS 111 service is available here.
    Dismiss Notice
Dismiss Notice
Find support, ask questions and share your experiences. Join the community »

Cannabis

Discussion in 'Community Submitted Guides & Links' started by Peter Reynolds, Mar 4, 2013.

  1. Peter Reynolds

    Peter Reynolds · Member

    Messages:
    6
    Likes Received:
    1
    Trophy Points:
    21
    Research on cannabis and cannabinoids related to diabetes:

    Cannabidiol Preserves Retinal Neurons and Reduces Vascular Permeability in Experimental Diabetes (abst - 2004)
    http://abstracts.iovs.org/cgi/content/a ... type=HWCIT
    The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats.
    (abst – 2004) http://www.ncbi.nlm.nih.gov/pubmed/15519750
    Cannabidiol lowers incidence of diabetes in non-obese diabetic mice (full - 2005) http://www.ncbi.nlm.nih.gov/pmc/article ... =pmcentrez
    Activation of the Peripheral Endocannabinoid System in Human Obesity
    (full - 2005) http://www.ncbi.nlm.nih.gov/pmc/article ... =pmcentrez
    Gpr40 Gene Expression in Human Pancreas and Insulinoma. (abst – 2005)
    http://www.ncbi.nlm.nih.gov/pubmed/16289108
    The Ffa Receptor Gpr40 Links Hyperinsulinemia, Hepatic Steatosis, and Impaired Glucose Homeostasis in Mouse. (abst – 2005)
    http://www.ncbi.nlm.nih.gov/pubmed/16054069
    Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes (full - 2006) http://www.ncbi.nlm.nih.gov/pmc/article ... ool=pubmed
    Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and ß-Pancreatic Cells and in Obesity and Hyperglycemia (full - 2006)
    http://jcem.endojournals.org/cgi/conten ... eb61349982
    Weight Control in Individuals With Diabetes (full - 2006)
    http://care.diabetesjournals.org/conten ... type=HWCIT
    415
    Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/17011761
    Expression of the Gene for a Membrane-bound Fatty Acid Receptor in the Pancreas and Islet Cell Tumours in Humans: Evidence for Gpr40 Expression in Pancreatic Beta Cells and Implications for Insulin Secretion. (abst – 2006)
    http://www.ncbi.nlm.nih.gov/pubmed/16525841
    The Cannabinergic System as a Target for Anti-inflammatory Therapies
    (abst - 2006) http://www.ingentaconnect.com/content/b ... 3/art00008
    Non-Psychoactive Cannabinoid Reduces Incidence Of Diabetes, Study Says
    (news - 2006) http://www.norml.org/index.cfm?Group_ID=6909
    Marijuana Compound May Help Stop Diabetic Retinopathy (news - 2006)
    http://www.sciencedaily.com/releases/20 ... 184647.htm
    Cannabidiol, a marijuana compound, may help stop diabetic retinopathy (news – 2006)
    http://www.xagena.it/news/medicinenews_ ... b6f17.html
    Marijuana Compound Offers Hope In Diabetic Retinopathy Prevention (news – 2006)
    http://www.bio-medicine.org/medicine-ne ... on-8121-1/
    Cannabidiol reduces the development of diabetes in an animal study (news - 2006)
    http://www.cannabis-med.org/english/bul ... p?id=219#3
    Getting Eye On Cannabinoids (news - 2006)
    http://www.thehempire.com/index.php/can ... nnabinoids
    Marijuana compound could prevent eye damage in diabetics (news - 2006)
    http://www.thehempire.com/index.php/can ... _diabetics
    Compound found in marijuana may defend against diabetic retinopathy (news – 2006)
    http://www.news-medical.net/news/2006/03/01/16284.aspx
    Cannabidiol arrests onset of autoimmune diabetes in NOD mice (full - 2007)
    http://safeaccess.ca/research/pdf/Weiss ... gy2007.pdf
    Expression of Cannabinoid CB1 Receptors in Models of Diabetic Neuropathy
    (full - 2007)
    http://jpet.aspetjournals.org/content/3 ... type=HWCIT
    Cannabidiol attenuates high-induced endothelial cell inflammatory response and barrier disruption (full - 2007) http://www.pubmedcentral.nih.gov/articl ... =pmcentrez
    416
    US Patent Application 20070099987 - Treating or preventing diabetes with cannabidiol
    (full – 2007) http://www.patentstorm.us/applications/ ... ltext.html
    Role of cannabinoid CB2 receptors in glucose homeostasis in rats (abst – 2007)
    http://www.sciencedirect.com/science/ar ... 990700249X
    The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochromocytoma PC12 cells (abst - 2007) http://lib.bioinfo.pl/pmid:17604177
    Anticoagulant Effects of a Cannabis Extract in an Obese Rat Model (abst - 2007)
    http://marijuana.researchtoday.net/archive/4/4/736.htm
    Mediation of Cannabidiol anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/article ... =pmcentrez
    The Role of Adipocyte Insulin Resistance in the Pathogenesis of Obesity-Related Elevations in Endocannabinoids (full – 2008)
    http://diabetes.diabetesjournals.org/co ... 50931c5e25
    GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/article ... =pmcentrez
    Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. (full – 2008)
    http://www.ncbi.nlm.nih.gov/pmc/article ... ool=pubmed
    Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet (full - 2008) http://www.nature.com/oby/journal/v16/n ... 7106a.html
    Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation. (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/article ... ool=pubmed
    Endocannabinoids and the Control of Energy Homeostasis (full – 2008)
    http://www.jbc.org/content/283/48/33021 ... d75bb49403
    Mediation of Cannabidiol Anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor (full – 2008) http://www.iovs.org/content/49/12/5526.full
    Effect of anandamide in improving of the non-adrenergic non-cholinergic relaxation of the corpus cavernosum from diabetic rats (abst – 2008) http://www.doaj.org/doaj?func=abstract& ... anguage=en
    417
    Presence of functional cannabinoid receptors in human endocrine pancreas.
    (abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18092149
    Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/article ... ool=pubmed
    Cannabinoids as novel anti-inflammatory drugs. (full - 2009)
    http://www.ncbi.nlm.nih.gov/pmc/article ... ool=pubmed
    Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/article ... ool=pubmed
    The endocanabinnoid system and diabetes - critical analyses of studies conducted with rimonabant (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/article ... =pmcentrez
    Biological effects of THC and a lipophilic cannabis extract on normal and insulin resistant 3T3-L1 adipocytes (abst - 2009)
    http://www.unboundmedicine.com/medline/ ... dipocytes_
    Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. (abst – 2009)
    http://www.ncbi.nlm.nih.gov/pubmed/19131941
    Beneficial effects of a Cannabis sativa extract on diabetes induced neuropathy and oxidative stress. (abst - 2009)
    http://www.unboundmedicine.com/medline/ ... ve_stress_
    Cannabis plant extracts could potentially form the basic ingredients for a market-leading diabetes drug (news – 2009)
    http://www.thefreelibrary.com/Cannabis+ ... 0202701009
    Medical Marijuana and Diabetes, Adult Onset (news – 2009)
    https://www.marijuanadoctors.com/conten ... dult-onset
    Expression and function of cannabinoid receptors in mouse islets. (full – 2010)
    http://www.landesbioscience.com/journal ... ETS2-5.pdf
    Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain (full - 2010)
    http://www.ncbi.nlm.nih.gov/pmc/article ... =pmcentrez
    Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/article ... ool=pubmed
    418
    Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy (full – 2010)
    http://diabetes.diabetesjournals.org/co ... ec5dfac384
    Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects. (full – 2010)
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003779/
    Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse MIN6 β-cells (full – 2010)
    http://content.karger.com/ProdukteDB/pr ... 320527.pdf
    Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients (full - 2010) http://www.lipidworld.com/content/9/1/43
    Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways.
    (full – 2010) http://diabetes.diabetesjournals.org/co ... ong#sec-25
    Cannabidiol protects retinal neurons by preserving glutamine synthetase activity in diabetes. (full - 2010) http://www.ncbi.nlm.nih.gov/pmc/article ... ool=pubmed
    Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
    (full - 2010) http://www.natap.org/2010/newsUpdates/marijuana.pdf
    Rehashing endocannabinoid antagonists: can we selectively target the periphery to safely treat obesity and type 2 diabetes? (full – 2010) http://www.jci.org/articles/view/44099?search[abstract_text]=&search[article_text]=cannabinoid&search[authors_text]=&search[fpage]=&search[title_text]=&search[volume]=
    Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. (full – 2010)
    http://www.ncbi.nlm.nih.gov/pmc/article ... ool=pubmed
    Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation.
    (full– 2010) http://www.wjgnet.com/1948-9358/full/v1/i1/12.htm
    Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20937249
    AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20816753
    419
    Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age. (abst – 2010) http://www.springerlink.com/content/g037q1lh40l15161/
    Endocannabinoid (EC) Receptor, CB1, and EC Enzymes' Expression in Primary Adipocyte Cultures of Lean and Obese Pre-pubertal Children in Relation to Adiponectin and Insulin (abst – 2010)
    http://www.degruyter.com/abstract/j/jpe ... annabinoid
    G1359A polymorphism in the cannabinoid receptor-1 gene is associated with metabolic syndrome in the Chinese Han population. (abst – 2010)
    http://www.ncbi.nlm.nih.gov/pubmed/20851297
    GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/21094910
    Pot Compound Mitigates Diabetic Cardiomyopathy (news - 2010)
    http://www.norml.org/index.cfm?Group_ID=8424
    Cannabinoids inhibit and may prevent neuropathic pain in diabetes. (news - 2010)
    http://medigardens.blogspot.com/2010/04 ... d-may.html
    Lab Notes: Pot Has Benefits for Diabetic Hearts (news - 2010)
    http://www.medpagetoday.com/LabNotes/LabNotes/23853
    A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans.
    (full – 2011) http://joe.endocrinology-journals.org/c ... 2/177.long
    Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161308/
    Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice (full– 2011)
    http://www.ncbi.nlm.nih.gov/pmc/article ... ool=pubmed
    Role for cannabinoid receptors in human proximal tubular hypertrophy. (full– 2011)
    http://content.karger.com/produktedb/pr ... 97&typ=pdf
    The association of the rs1049353 polymorphism of the CNR1 gene with hypoadiponectinemia. (full – 2011) http://www.rjme.ro/RJME/resources/files ... 791795.pdf
    Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis (abst – 2011) http://diabetes.diabetesjournals.org/co ... 5.abstract
    Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic β-Cells (abst – 2011)
    http://diabetes.diabetesjournals.org/co ... ec5dfac384
    420
    Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21340622
    Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans. (abst – 2011)
    http://www.unboundmedicine.com/medline/ ... angerhans_
    Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes. (abst – 2011)
    http://www.unboundmedicine.com/medline/ ... _Diabetes_
    Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21238581
    Win 55,212-2 reduces cardiac ischaemia-reperfusion injury in zucker diabetic fatty rats: role of cb2 receptors and cardiac inos/enos expression. (abst – 2011)
    http://www.unboundmedicine.com/medline/ ... xpression_
    GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms (abst – 2011)
    http://endo.endojournals.org/content/15 ... a533824b24
    Variants at the endocannabinoid receptor CB1 gene (CNR1) and insulin sensitivity, type 2 diabetes, and coronary heart disease. (abst – 2011)
    http://www.ncbi.nlm.nih.gov/pubmed/21633404
    Cannabidiol Dampens Streptozotocin-Induced Retinal Inflammation by Targeting of Microglial Activation (abst - 2011)
    http://abstracts.iovs.org/cgi/content/a ... type=HWCIT
    The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22029844
    The Endocannabinoid System: Plant-Derived Cannabinoids in Diabetes and Diabetic Complications. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22155112
    TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21752941
    Takeda moves potential first-in-class diabetes drug into phase III (news – 2011)
    http://www.inpharm.com/news/166980/take ... -phase-iii
    421
    Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III. (full – 2012)
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289985/
    The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119. (full - 2012)
    http://onlinelibrary.wiley.com/doi/10.1 ... 755.x/full
    The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity.
    (full – 2012) http://diabetes.diabetesjournals.org/co ... 2/281.long
    Endocannabinoids measurement in human saliva as potential biomarker of obesity.
    (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/article ... ool=pubmed
    Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series (full – 2012)
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500919/
    Type 2 Diabetes Associated Changes in the Plasma Non-Esterified Fatty Acids, Oxylipins and Endocannabinoids (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493609/
    Excess of the endocannabinoid anandamide during lactation induces overweight, fat accumulation and insulin resistance in adult mice (full – 2012)
    http://www.dmsjournal.com/content/4/1/35
    Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant
    (full – 2012) http://www.nutritionj.com/content/11/1/50
    Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372498/
    Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice (full – 2012) http://www.lipidworld.com/content/11/1/98
    Islet protection and amelioration of diabetes type 2 in Psammomys obesus by treatment with cannabidiol (link to PDF - 2012)
    http://www.scirp.org/journal/PaperInfor ... erID=17302
    Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22609797
    Overexpression of cannabinoid CB2 receptor in the brain induces hyperglycaemia and a lean phenotype in adult mice. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22487302
    422
    Induction of Glucose Intolerance by Acute Administration of Rimonabant.
    (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22678147
    TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial. (abst – 2012)
    http://www.ncbi.nlm.nih.gov/pubmed/22374408
    Stimulating beta cell replication and improving islet graft function by GPR119 agonists.
    (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21902730
    A Randomized, Double-Blind, Placebo Controlled, Parallel Assignment, Flexible Dose, Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain Using an Enriched Enrollment Randomized Withdrawal Design (S38.003) (abst – 2012) http://www.neurology.org/cgi/content/me ... type=HWCIT
    The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models (abst – 2012)
    http://jpet.aspetjournals.org/content/3 ... bb89fd59f5
    G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the presence of coronary artery disease in patients with type 2 diabetes. (abst – 2012)
    http://www.ncbi.nlm.nih.gov/pubmed/22138970
    A Multiple-Ascending-Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Novel GPR40 Agonist, TAK-875, in Subjects With Type 2 Diabetes. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22669289
    Optimization of (2,3-dihydro-1-benzofuran-3-yl)acetic acids: discovery of a non-free fatty acid-like, highly bioavailable G protein-coupled receptor 40/free fatty acid receptor 1 agonist as a glucose-dependent insulinotropic agent. (abst – 2012)
    http://www.ncbi.nlm.nih.gov/pubmed/22490067
    An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22921260
    The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity. (abst – 2012)
    http://www.ncbi.nlm.nih.gov/pubmed/22943701
    Reports of the death of CB1 antagonists have been greatly exaggerated: recent preclinical findings predict improved safety in the treatment of obesity. (abst – 2012)
    http://www.ncbi.nlm.nih.gov/pubmed/22743603
    423
    Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats.
    (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22959964
    New vistas for treatment of obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of energy balance. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22674489
    Chronic activation of cannabinoid receptors in vitro does not compromise mouse islet function. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23078523
    The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity (abst – 2012) http://onlinelibrary.wiley.com/doi/10.1 ... x/abstract
    Synthetic cannabinoid could treat pain in diabetes patients (news – 2012)
    http://www.medwirenews.com/57/102248/Di ... ents_.html
    Study: Synthetic THC Analogue Mitigates Diabetic Neuropathy, Is 'Well Tolerated' In Patients (news – 2012)
    http://norml.org/news/2012/09/20/study- ... n-patients
    New drug offers novel pain management therapy for diabetics. (news - 2012)
    http://www.thefreelibrary.com/New+drug+ ... 0306899453
    Drug offers new pain management therapy for diabetics (news – 2012)
    http://medicalxpress.com/news/2012-10-d ... etics.html
    Is the cardiovascular system a therapeutic target for cannabidiol? (abst – 2013)
    http://onlinelibrary.wiley.com/doi/10.1 ... x/abstract
    Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids (abst – 2013) http://www.nature.com/neuro/journal/vao ... .3321.html
     
    • Like Like x 1
  2. peterlemer

    peterlemer · Well-Known Member

    Messages:
    63
    Likes Received:
    9
    Trophy Points:
    28
    perfect! thanks :)

    pete
     
  3. Spiritheal

    Spiritheal · Newbie

    Messages:
    1
    Likes Received:
    0
    Trophy Points:
    21
    Wow Peter, you've certainly been doing your research. It will take me some time to digest it all although I'm sure it will be very interesting. Thank you very much for all this data and the time you have taken to post it.
     
  4. Tinkle

    Tinkle Type 1 · Well-Known Member

    Messages:
    93
    Likes Received:
    85
    Trophy Points:
    58
    Well that's enough to make a curious person visit Amsterdam! Along with the Mona Lisa that is ✈️


    Sent from the Diabetes Forum App
     
    • Winner Winner x 1
  5. CollieBoy

    CollieBoy Type 2 · Well-Known Member

    Messages:
    2,974
    Likes Received:
    5,573
    Trophy Points:
    178
    Problem is, the Mona Lisa is in Paris, in The Louvre.<G>
     
  6. Tinkle

    Tinkle Type 1 · Well-Known Member

    Messages:
    93
    Likes Received:
    85
    Trophy Points:
    58
  7. Giverny

    Giverny Friend · Admin
    Administrator

    Messages:
    1,680
    Likes Received:
    1,388
    Trophy Points:
    198
    Amsterdam is a really lovely city! I went there not long ago, and I'd recommend it to anyone whether you wish to erm... 'indulge' in their cannabis culture or not. Plenty to do either way ;)
     
    • Like Like x 2
  8. CollieBoy

    CollieBoy Type 2 · Well-Known Member

    Messages:
    2,974
    Likes Received:
    5,573
    Trophy Points:
    178
    Yes, well worth it <G>
     
  9. Jaylee

    Jaylee Type 1 · Moderator
    Staff Member

    Messages:
    15,377
    Likes Received:
    11,532
    Trophy Points:
    298
    Sadly not anymore... They have clamped down on the drugs tourism & only Dutch nationals may frequent the "coffee shops" now..
    From what I was told even the Dutch have to register for an ID card to purchase cannabis from licences outlets, which in doing so will put them on a "drug users register". So even the occasional cannabis user could ruin chances of employment or job prospects in signing up to this scheme....
     
  10. Giverny

    Giverny Friend · Admin
    Administrator

    Messages:
    1,680
    Likes Received:
    1,388
    Trophy Points:
    198
    That definitely isn't the case. I went in November and a friend of mine is there right now!
     
  11. Jaylee

    Jaylee Type 1 · Moderator
    Staff Member

    Messages:
    15,377
    Likes Received:
    11,532
    Trophy Points:
    298
    I was in North Holland the end of the year before last.. I went into an establishment to have a nose about for old times sake...
    I had heard about this new legislation & to my surprise it had been enforced about two months previously.. The woman behind the counter couldn't sell me some if she wanted to.. Coming out the premises (clean I might add.) we got in my van & headed out of the adjacent car park.
    I was stopped buy two Dutch cycle cops & questioned.. One picked up on my short term licence.. They bid me a pleasant stay & sent me on my way.
    However they spotted the British plates & me & my wife leaving a dope shop.. What I was told about the ID card was by a Dutch restraint owner that evening at a campsite in North Holland who was generous enough to let me have a little foliage....

    That's all I know... I by no means wish to give out misinformation or contradict Giverny.. Even as far back as 6 years ago they started checking ID as we entered such premises (passports/driving licences.) & we were all clearly over 35... Lol
    I initially thought this thread was from about three years back & was surprised to see the dating more recent..
     
  12. Giverny

    Giverny Friend · Admin
    Administrator

    Messages:
    1,680
    Likes Received:
    1,388
    Trophy Points:
    198
    That's really weird. I think they tried to change the legislation a while ago but they reversed the decision after seeing the decline in business. Talking about it really makes me want to go again, what a lovely city Amsterdam is :)
     
    • Like Like x 2
  13. Jaylee

    Jaylee Type 1 · Moderator
    Staff Member

    Messages:
    15,377
    Likes Received:
    11,532
    Trophy Points:
    298
  • Meet the Community

    Find support, connect with others, ask questions and share your experiences with people with diabetes, their carers and family.

    Did you know: 7 out of 10 people improve their understanding of diabetes within 6 months of being a Diabetes Forum member. Get the Diabetes Forum App and stay connected on iOS and Android

    Grab the app!
  • Tweet with us

  • Like us on Facebook